Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

NCT06067737 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Psilocybin
DRUG: Psilocybin

Sponsor

Johns Hopkins University